NCT00580567

Brief Summary

The purpose of the this study is to compare pathological gamblers versus non-pathological gamblers using tests that measure different components of impulsivity. We aim to invite a total of 120 individuals to participate in this study. Impulsivity has been described as the cognitive inability to delay gratification, a failure to inhibit behavioral action or acting without forethought about consequences. Impulsivity has also been seen as a personality trait characterized by risk-taking or sensation seeking behavior. Pathological gamblers demonstrate aspects of impulsivity; they act without thinking, have difficult inhibiting urges to gamble and desire immediate gratification. The goal of this project is to clarify which components of impulsivity are associated with pathological gambling. Non-treatment seeking, pathological gamblers and controls will be recruited from the community and local casinos. Each participant will be administered a battery of tests that represent different operational definitions of impulsivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 24, 2007

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

June 4, 2013

Status Verified

June 1, 2013

Enrollment Period

2.4 years

First QC Date

December 20, 2007

Last Update Submit

June 3, 2013

Conditions

Keywords

ImpulsivityGamblingPathological GamblersProblem GamblersNon-Pathological GamblersRisk-takingInhibitionGambling Severity

Outcome Measures

Primary Outcomes (1)

  • Barratt Impusivity Scale

    12 months

Study Arms (2)

1

Pathological Gamblers

2

Non-Pathological Gamblers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Community Sample

You may qualify if:

  • years or older
  • Be able to speak, read and write in English
  • Current diagnosis of pathological gambling (using DSM-IV criteria)
  • South Oaks Gambling Screen (SOGS) score of 5 or above during screening
  • Recent gambling activity -- at least once within one week prior to enrollment.
  • Voluntarily given informed consent and signed the informed consent document.
  • Not currently seeking treatment for gambling
  • years or older
  • Be able to speak, read and write in English
  • South Oaks Gambling Screen (SOGS) score of 5 or less during screening
  • Voluntarily given informed consent and signed the informed consent document
  • Does not meet diagnosis of pathological gambling by DSM-IV criteria
  • Not currently seeking treatment for gambling

You may not qualify if:

  • Current treatment for pathological gambling, excluding involvement with Gamblers Anonymous
  • Ongoing medication for any psychiatric disorders, including anti-psychotics, antidepressants, mood stabilizers, anxiolytics or sedative/hypnotics.
  • Dependence by DSM-IV criteria on any psychoactive substance, excluding caffeine or nicotine
  • Presence of clinically unstable medical disorders that could harm the subject if not treated immediately.
  • Presence of any neurological or psychiatric disorders (as assessed by the SCID or MINI and BDI-II) that would require immediate treatment.
  • Test positive urine toxicology for illicit drugs prior to enrollment
  • Hamilton Depression Scale score of \>17

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Neuropsychiatric Institute

Los Angeles, California, 90095, United States

Location

Related Links

MeSH Terms

Conditions

GamblingImpulsive BehaviorRisk-TakingInhibition, Psychological

Condition Hierarchy (Ancestors)

BehaviorDisruptive, Impulse Control, and Conduct DisordersMental Disorders

Study Officials

  • Timothy W. Fong, M.D.

    UCLA Gambling Studies Program

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 24, 2007

Study Start

March 1, 2007

Primary Completion

August 1, 2009

Study Completion

August 1, 2009

Last Updated

June 4, 2013

Record last verified: 2013-06

Locations